Etrans is expanding its dedicated life sciences team in response to sustained demand from pharmaceutical, medical-device, clinical-research and healthcare clients. The expansion adds specialist translators and reviewers across our most requested language pairs and strengthens our established processes for high-stakes medical content.
Why now
Demand for life sciences language services has grown steadily for years, and the reasons are structural rather than temporary. Clinical trials continue to internationalise, with sponsors conducting studies across an ever wider range of countries. Regulators expect accurate local-language documentation, and patient-facing materials must be both technically correct and genuinely readable.
At the same time, device manufacturers, digital-health companies and healthcare publishers are producing more content for global markets than ever before. Our clients tell us repeatedly that finding linguists who understand both the science and the regulatory context is among their hardest supply challenges.
Who we are adding
The expansion is deliberately focused on expertise. New team members include translators and reviewers with education or professional backgrounds in areas such as medicine, pharmacy, biology and biomedical engineering, alongside proven translation experience. All work into their native languages and are being integrated into our quality system under the same selection and review standards that apply to every Etrans linguist.
We are also strengthening the reviewer layer, because independent review by a second specialist is essential for clinical and regulatory documents and a requirement we will not compromise on, whatever the schedule pressure.
The content we support
The life sciences team handles the full range of materials clients require throughout product development and commercialisation:
- clinical-trial documents, including protocols and informed-consent forms;
- regulatory submissions and correspondence with authorities;
- labelling, package inserts and instructions for use;
- patents and technical documentation for devices;
- marketing materials that remain compliant with advertising rules;
- patient-reported outcomes, questionnaires and training materials.
Process and technology investments
Expanding the team is being paired with investment in the infrastructure that supports specialist work. Client-specific termbases capture approved terminology and product names; translation memory maintains consistency across large programmes and successive studies; and quality tools automatically flag number discrepancies and unapproved terms before human review.
Our policies on machine translation remain deliberately conservative for life sciences content: technology assists with drafts of suitable material, but every patient-facing or regulatory text passes through expert linguists, with complete traceability and confidentiality protections that reflect the sensitivity of clinical and commercial information.
Training and internal alignment
New specialists are integrated deliberately rather than left to learn conventions independently. Induction covers our quality system, confidentiality expectations and the practical use of client assets, while project-specific briefings align everyone involved on terminology, register and the particular requirements of the documents. Early assignments are closely reviewed, not from distrust but because consistent habits formed at the beginning protect every later project.
We also connect new linguists with experienced reviewers, because the questions worth asking in life-sciences work are often subtle, and direct access to that experience raises quality considerably faster than written guidance alone.
Working with clients' regulatory teams
Much of the value in specialist work emerges from how it is coordinated, not merely who translates it. For life-sciences clients, project teams align early with regulatory and quality colleagues, confirming conventions for terminology, document templates, version control and the evidence required for submissions. That preparation prevents the late disagreements, over a single term or format, that otherwise hold up carefully planned timelines.
We also adapt to each client's systems rather than imposing our own: files arrive in the formats they already use, review comments are managed through agreed channels, and records support the traceability that regulated work demands. Over successive programmes, this makes Etrans feel less like an external vendor and more like an extension of the client's own team, which is precisely the relationship we aim to build.
A long-term commitment
The life sciences are not an area a company enters lightly. Our practice has been built over many years, through repeated work with demanding clients who measure their partners in accuracy and reliability rather than price alone. This expansion recognises that the sector will remain central to the company's future.
We look forward to supporting both long-standing clients and new partners as they develop, regulate and deliver products that ultimately serve patients. Helping accurate scientific and medical information reach the people who need it, in a language they understand, is among the most meaningful work our profession offers.